Medical treatment update on pulmonary arterial hypertension (original) (raw)

Practical Considerations for the Pharmacotherapy of Pulmonary Arterial Hypertension

Vincent Mauro

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012

View PDFchevron_right

Novel Medical Therapies for Pulmonary Arterial Hypertension

Dermot O'Callaghan

Clinics in Chest Medicine, 2013

View PDFchevron_right

The Current Treatments Of Pulmonary Arterial Hypertension

G Bouts

2020

View PDFchevron_right

Endothelin receptor antagonists in pulmonary arterial hypertension

O. Sitbon

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology, 2010

View PDFchevron_right

Therapeutic Strategies in Pulmonary Arterial Hypertension

R. Poscia

European Cardiology Review, 2012

View PDFchevron_right

Therapeutic advances in pulmonary arterial hypertension

David Montani

Therapeutic advances in respiratory disease, 2008

View PDFchevron_right

Efficacy, safety and clinical pharmacology of macitentan in comparison to other endothelin receptor antagonists in the treatment of pulmonary arterial hypertension

Jasper Dingemanse

Expert Opinion on Drug Safety, 2014

View PDFchevron_right

Current Pharmacological Treatment of Pulmonary Arterial Hypertension

Paschalis Steiropoulos

Current Clinical Pharmacology, 2008

View PDFchevron_right

Perspectives on oral pulmonary hypertension therapies recently approved by the u.s. Food and drug administration

Nicholas Hill, H. Farber

Annals of the American Thoracic Society, 2015

View PDFchevron_right

The potential for macitentan, a new dual endothelin receptor antagonist, in the treatment of pulmonary arterial hypertension

Alexandru Steriade

Therapeutic advances in respiratory disease, 2014

View PDFchevron_right

Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension

Dermot O'Callaghan

Expert Opinion on Pharmacotherapy, 2011

View PDFchevron_right

Perspectives On Oral Pulmonary Hypertension Therapies Recently Approved by the Food and Drug Administration

Charles D Burger

Annals of the American Thoracic Society, 2013

View PDFchevron_right

Management Of Pulmonary Arterial Hypertension: A Brief Overview

Shatavisa Mukherjee

2017

View PDFchevron_right

Advances in medical therapy for pulmonary arterial

Tomas Pulido

View PDFchevron_right

Clinical Pharmacology of Endothelin Receptor Antagonists Used in the Treatment of Pulmonary Arterial Hypertension

Christophe Guignabert

American Journal of Cardiovascular Drugs, 2014

View PDFchevron_right

New Insights in the Treatment Strategy for Pulmonary Arterial Hypertension

Ryozo Nagai

Cardiovascular Drugs and Therapy, 2006

View PDFchevron_right

Macitentan for the treatment of pulmonary arterial hypertension

Cyrus Kholdani

Vascular health and risk management, 2014

View PDFchevron_right

Key Articles and Guidelines in the Management of Pulmonary Arterial Hypertension: 2011 Update

Tyree Kiser

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012

View PDFchevron_right

Secondary pulmonary arterial hypertension: treated with endothelin receptor blockade

Tarek Kashour

Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital, 2005

View PDFchevron_right

Targeted therapies in pulmonary arterial hypertension

Christophe Guignabert, Vincent Algalarrondo

Pharmacology and Therapeutics, 2014

View PDFchevron_right

A Focus on Macitentan in the Treatment of Pulmonary Arterial Hypertension

Ulf Simonsen

Basic & clinical pharmacology & toxicology, 2018

View PDFchevron_right

Pulmonary arterial hypertension outcomes upon endothelin-1 receptor antagonist switch to macitentan

Kathryn M Hird

Journal of International Medical Research

View PDFchevron_right

Macitentan: An important addition to the treatment of pulmonary arterial hypertension

Anjan Khadka

Journal of Pharmacology and Pharmacotherapeutics, 2015

View PDFchevron_right

Actual and novel treatments for pulmonary hypertension

Thomas Unger

Hypertension News, 2021

View PDFchevron_right

Macitentan: a review of its use in patients with pulmonary arterial hypertension

Sohita Dhillon

Drugs, 2014

View PDFchevron_right

New approaches to the treatment of pulmonary hypertension: from bench to bedside

Bobby Nossaman

Cardiology in review

View PDFchevron_right

Recent Trends in the Management of Pulmonary Hypertension

Mukhyaprana Prabhu

2005

View PDFchevron_right

New perspectives for the treatment of pulmonary hypertension

Adrian Hobbs

British Journal of Pharmacology, 2011

View PDFchevron_right

Differential vasoactive response to endothelin receptor antagonists and prostacyclin in patients with severe pulmonary hypertension

Sotiria Apostolopoulou

Clinical science (London, England : 1979), 2002

View PDFchevron_right

A review of pulmonary arterial hypertension: Part 2: Current and expected treatments

Pieter E Postmus

View PDFchevron_right

Evidence for the use of combination targeted therapeutic approaches for the management of pulmonary arterial hypertension

Dermot O'Callaghan

Respiratory Medicine, 2010

View PDFchevron_right

Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients Receiving Background Endothelin Receptor Antagonist and Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C2 Study)

Jeremy Feldman

CHEST Journal, 2013

View PDFchevron_right

Pharmacotherapy in pulmonary arterial hypertension: a systematic review and meta-analysis

Shalini Nayar

Respiratory Research, 2010

View PDFchevron_right

Pulmonary Hypertension - New Trends of Diagnostic and Therapy

Sabina Prevljak

Medical Archives, 2016

View PDFchevron_right

Pulmonary Arterial Hypertension: Need to Treat

Fotis Sampsonas

2008

View PDFchevron_right